Moneycontrol PRO
UPCOMING EVENT:Attend Traders Carnival Live. 3 days 12 sessions at Rs.1599/-, exclusive for Moneycontrol Pro subscribers. Register now!
you are here: HomeNewsIndia

India records 23,529 new COVID-19 cases, 311 deaths

The national COVID-19 recovery rate was recorded at 97.85 percent, the highest since March 2020, the health ministry said.

September 30, 2021 / 10:38 AM IST
A decrease of 5,500 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.

A decrease of 5,500 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.

India recorded a single-day rise of 23,529 COVID-19 cases on Thursday, taking its infection tally to 3,37,39,980, while the count of active cases dipped to 2,77,020, the lowest in 195 days, according to Union Health Ministry data.

The death toll due to the disease has climbed to 4,48,062 with 311 daily fatalities being recorded, according to the data updated at 8 am.

The number of active cases has declined to 2,77,020, comprising 0.82 percent of the total infections – the lowest since March 2020, the ministry said.

The national COVID-19 recovery rate was recorded at 97.85 percent, the highest since March 2020, it added.

A decrease of 5,500 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Also, 15,06,254 COVID-19 tests were conducted in the country on Wednesday, taking the total number of such examinations done so far to 56,89,56,439, the data showed.

The daily positivity rate was recorded at 1.56 percent. It has been below three per cent for 31 days.

The weekly positivity rate was recorded at 1.74 percent. This figure has been below three per cent for 97 days, according to the health ministry.

The number of people who have recuperated from the disease has surged to 3,30,14,898, while the case fatality rate was recorded at 1.33 percent.

The cumulative number of coronavirus vaccine doses administered in the country so far under the nationwide inoculation drive has exceeded 88.34 crore.
PTI
first published: Sep 30, 2021 10:37 am

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark